ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.657 USD | +1.60% |
|
+1.46% | +4.26% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 1.15 USD | +1.77% | -2.54% | +9.52% | -.--% | ||
| 10.69 USD | -1.02% | 0.00% | -4.81% | -.--% | ||
| 3.26 USD | 0.00% | -11.17% | -22.57% | -.--% | ||
| 64.97 USD | +0.02% | -.--% | +240.87% | -.--% | ||
| 54.84 USD | +1.67% | -3.02% | +99.42% | -.--% | ||
| 58.53 USD | -1.45% | -6.53% | +6.15% | -.--% | ||
| 56.24 USD | -5.64% | -11.52% | -10.16% | -.--% | ||
| 56.12 USD | +2.80% | +3.14% | +1.12% | -.--% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/06/24 | 6.657 | +1.60% | 8 503 |
| 21/06/24 | 6.552 | +2.36% | 3,154 |
| 20/06/24 | 6.401 | 0.00% | 820 |
| 19/06/24 | 6.401 | -1.26% | 320 |
| 18/06/24 | 6.483 | -0.73% | 0 |
Other stock markets
Delayed Quote Swiss Exchange
Last update June 24, 2024 at 01:34 pm
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
18/10/2017
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 30/05/2024 )
| AuM (EUR) | 439 M€ |
|---|---|
| AuM 1M | 428 M€ |
| AuM 3 months | 426 M€ |
| AuM 6 months | 364 M€ |
| AuM 12 months | 433 M€ |
- Stock Market
- ETF
- BTEC ETF
